Michael Boucher, MD
Psychiatry · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 16 years
- Perelman School of Med at the University of Pennsylvania, 2010
Offices
2 locations · UC Regents · 148 clinicians in this group
Hospitals listed: Ronald Reagan UCLA Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Boucher’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A121151 · Current
Licensed to practise in California · since 2012 · expires 2028-05-31 · University of Pennsylvania School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ronald Reagan UCLA Medical CenterLos Angeles, CAAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of Jonsson Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 6.27 (4.69 to 7.85) · 3,570 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 5.17 (1.78 to 8.56) · 1,778 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.21 (0 to 0.62) · 8,165 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.59, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.611, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.503, Oct 2024 – Sep 2025
See every measure and the patient survey for Ronald Reagan UCLA Medical Center
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 6.27 (4.69 to 7.85) · 3,570 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.17 (1.78 to 8.56) · 1,778 cases | Better | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.62) · 8,165 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.59 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.611 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.503 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.67 (0 to 1.44) · 2,883 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.7 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 171.14 (139.88 to 202.41) · 282 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 122 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 49 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.5 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.9 · 350 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.1 · 436 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.8 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.4 · 3,004 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 9,102 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.09 to 0.44) · 10,460 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.67 (0.57 to 2.77) · 1,972 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.27 to 3.44) · 3,000 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.93 (3.76 to 8.09) · 2,101 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.65 (1.31 to 3.98) · 1,032 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.56 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.626 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 138 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 357 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -7.1 · 122 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -12.9 · 385 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 13.6 · 427 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 404 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.7 to 6.5) · 609 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.3 (10.1 to 15) · 609 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.8 · 119 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.8 (8.5 to 13.7) · 2,701 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,463 cases | No different | Jan 2024 – Dec 2024 |
What patients said (814 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$13,830
Medicare paid this office $13,830 for 34 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 21 | $6,576 | $103 |
Who their Medicare patients are
34 Original Medicare patients in 2024. Average age 55 · Under 65 65% · 85 and older 0% · Women 56% · Also on Medicaid 50% · Health risk score 1.81. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75% · High blood pressure 68% · Diabetes 41% · Coronary heart disease 32%.
The office billed $100,159, Medicare allowed $17,966 and paid $13,830; for 159 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 34 | 159 | 55 | 1.81 | $100,159 | $13,830 |
| 2023 | 55 | 215 | 55 | 1.57 | $139,927 | $20,055 |
| 2022 | 63 | 258 | 56 | 1.29 | $167,801 | $21,813 |
| 2021 | 59 | 219 | 55 | 1.50 | $139,152 | $19,298 |
| 2020 | 57 | 265 | 49 | 1.43 | $117,832 | $22,542 |
| 2019 | 92 | 424 | 59 | 1.84 | $175,985 | $33,672 |
| 2018 | 124 | 449 | 61 | 1.80 | $156,870 | $28,080 |
| 2017 | 122 | 520 | 59 | 1.93 | $162,337 | $32,146 |
| 2016 | 123 | 604 | 62 | 2.16 | $173,229 | $42,810 |
| 2015 | 102 | 380 | 62 | 1.91 | $93,606 | $23,626 |
| 2014 | 44 | 215 | 55 | 1.41 | $55,402 | $14,212 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $8,264 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $4,884 | $68 |
| Return visit (30+ min) | 24 | $2,784 | $99 |
2022: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $11,873 | $88 |
| Return visit (30+ min) | 28 | $3,449 | $99 |
2021: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $9,932 | $89 |
| Return visit (30+ min) | 18 | $3,040 | $105 |
2020: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $16,069 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $2,352 | $62 |
2019: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $19,459 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $9,067 | $62 |
| Psychiatric diagnostic evaluation with medical services | 11 | $1,332 | $121 |
| Short return visit (20+ min) | 13 | $726 | $48 |
2018: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 81 | $21,742 | $59 |
| Psychiatric diagnostic evaluation with medical services | 21 | $2,502 | $119 |
| Short return visit (20+ min) | 27 | $1,717 | $46 |
2017: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $25,456 | $60 |
| Psychiatric diagnostic evaluation with medical services | 24 | $2,741 | $110 |
| Short return visit (20+ min) | 27 | $2,559 | $56 |
2016: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 61 | $23,524 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $10,835 | $88 |
| Psychiatric diagnostic evaluation with medical services | 31 | $3,893 | $115 |
| Short return visit (20+ min) | 15 | $948 | $47 |
2015: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 61 | $18,523 | $60 |
| Psychiatric diagnostic evaluation with medical services | 21 | $2,244 | $107 |
2014: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $9,227 | $60 |
| Psychiatric diagnostic evaluation with medical services | 20 | $2,423 | $115 |
| Hospital discharge day management, 30 minutes or less | 11 | $672 | $61 |
Medicaid work
$3,830 in 2019
Medicaid paid $3,830 for 118 billed services this clinician did in 2019, up to 42 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Service | 95 | $3,596 |
| Service | 23 | $234 |
| 2019 | 118 | 2 | 42 | $3,830 |
| 2018 | 33 | 1 | 19 | $1,358 |
See the largest Medicaid services in earlier years
2018
| Service | 33 | $1,358 |
Drugs they prescribed that Part D paid
$7,476
Pharmacies billed $7,476 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 96) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
81 generic and 15 brand-name prescriptions · $7,476 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dextroamphetamine-Amphetamine | 16 | $300 | $19 |
| Clonazepam | 13 | $143 | $11 |
| Alprazolam | 12 | $15 | $1 |
| Clonidine | 11 | $8 | $1 |
Year by year
| 2024 | 96 | None | 0% (0) | 16% | $7,476 |
| 2023 | 102 | 15 | 0% (0) | 21% | $15,880 |
| 2022 | 119 | 17 | 0% (0) | None | $18,865 |
| 2021 | 88 | 25 | 0% (0) | 17% | $12,380 |
| 2020 | 104 | 25 | 0% (0) | None | $4,301 |
| 2019 | 181 | 53 | 0% (0) | None | $10,271 |
| 2018 | 345 | 70 | None | 9% | $29,967 |
| 2017 | 513 | 70 | None | 10% | $47,765 |
| 2016 | 343 | 56 | None | 9% | $18,089 |
| 2015 | 162 | 37 | None | 12% | $9,003 |
| 2014 | 73 | 24 | 0% (0) | 22% | $6,320 |
| 2013 | 170 | 20 | 0% (0) | 9% | $33,053 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Dextroamphetamine-Amphetamine | 11 | $561 | $51 |
2022: 4 drugs
| Adderall Xr | 12 | $2,606 | $217 |
| Clozapine | 14 | $350 | $25 |
| Dextroamphetamine-Amphetamine | 21 | $291 | $14 |
| Diazepam | 11 | $34 | $3 |
2021: 1 drug
| Dextroamphetamine-Amphetamine | 13 | $757 | $58 |
2019: 4 drugs
| Duloxetine | 13 | $665 | $51 |
| Quetiapine | 12 | $360 | $30 |
| Trazodone | 12 | $165 | $14 |
| Olanzapine | 12 | $148 | $12 |
2018: 9 drugs
| Aripiprazole | 23 | $2,545 | $111 |
| Clozapine | 20 | $948 | $47 |
| Duloxetine | 16 | $642 | $40 |
| Trazodone | 33 | $474 | $14 |
| Quetiapine | 18 | $441 | $25 |
| Bupropion Xl | 13 | $263 | $20 |
| Gabapentin | 17 | $201 | $12 |
| Fluoxetine | 19 | $136 | $7 |
| Sertraline | 15 | $105 | $7 |
2017: 12 drugs
| Aripiprazole | 30 | $10,581 | $353 |
| Duloxetine | 45 | $2,082 | $46 |
| Gabapentin | 29 | $1,237 | $43 |
| Clozapine | 12 | $1,180 | $98 |
| Quetiapine | 32 | $697 | $22 |
| Trazodone | 43 | $353 | $8 |
| Olanzapine | 27 | $334 | $12 |
| Fluoxetine | 11 | $207 | $19 |
| Escitalopram | 20 | $192 | $10 |
| Propranolol | 12 | $180 | $15 |
| Lamotrigine | 24 | $177 | $7 |
| Sertraline | 18 | $108 | $6 |
2016: 8 drugs
| Duloxetine | 36 | $1,313 | $36 |
| Clozapine | 17 | $1,298 | $76 |
| Bupropion Xl | 17 | $388 | $23 |
| Fluoxetine | 15 | $305 | $20 |
| Olanzapine | 26 | $221 | $9 |
| Trazodone | 19 | $211 | $11 |
| Quetiapine | 15 | $168 | $11 |
| Risperidone | 17 | $118 | $7 |
2015: 2 drugs
| Quetiapine | 11 | $137 | $12 |
| Trazodone | 11 | $73 | $7 |
2013: 4 drugs
| Olanzapine | 24 | $11,932 | $497 |
| Clozapine | 16 | $1,979 | $124 |
| Bupropion Xl | 22 | $1,176 | $53 |
| Zolpidem | 13 | $92 | $7 |
Money from drug and device companies
$27 in 2024
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Cobenfy | $27 | 1 payment
|
See the published payment
| E.R. Squibb & Sons L.L.C. | Education · 2024-11-04 | Cobenfy | $27 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1053638932
- Licence
- CA 121151California A121151: Current · expires 2028-05-31
- Trained
- Perelman School of Med at the University of Pennsylvania, 2010 · 16 years ago
- Group
- UC Regents
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 5767 W Century Blvd Ste 400, Los Angeles, CA, 90045
- NPI first listed
- 2010-04-30
- NPI last updated
- 2024-07-17
- NPI record certified
- 2024-07-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 760 Westwood Plz, Los Angeles, CA, 90024